Author(s):
Keerthana Chandrasekar, Taroob Runa T, Soorya U, Serolin S R, Manojkumar V
Email(s):
keerthananandar@gmail.com , taroobruna@gmail.com , sooryaudayakumar37536@gmail.com , serolin2@gmail.com , manojneat29@gmail.com
DOI:
10.52711/0974-360X.2025.00033
Address:
Keerthana Chandrasekar*, Taroob Runa T, Soorya U, Serolin S R, Manojkumar V
Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamil Nadu, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 1,
Year - 2025
ABSTRACT:
Linezolid (LZD) being a narrow therapeutic index drug and having limited clinical data in pediatric hospitalized patients, taking account of the risks of both overdose and underdose and the complexity of the modified pharmacokinetic behavior in pediatric subjects, optimizing the dosage is necessary. This study is proposed to optimize the dosage regimen in the South Indian pediatric population using the population pharmacokinetics approach. The study was done using the standardized protocol, Albendazole was selected as the internal standard. To ascertain Linezolid serum concentration, HPLC was employed modified from a partially validated method and the data analyses were done using PUMAS - AI software. The bioanalytical method adopted for the quantification of the study drug in the plasma was found robust and validated as per the recommended standards. In this study, the clearance and volume of distribution of Linezolid were estimated to be, 0.49L/hour with a 43% variance and 0.14L/hour with a 32% variance. 2 out of 5 patients experienced thrombocytopenia [40%], hence dosage adjustment should be recommended in those patients. Using bootstrap analysis, the model was validated internally, and the results demonstrated statistical significance. Further studies must be undertaken with larger sample sizes and a greater number of plasma samples, to determine the covariates influencing the primary pharmacokinetic parameters.
Cite this article:
Keerthana Chandrasekar, Taroob Runa T, Soorya U, Serolin S R, Manojkumar V. Dosage Optimization of Linezolid using Population Pharmacokinetics in South - Indian Pediatric Population. Research Journal of Pharmacy and Technology. 2025;18(1):217-0. doi: 10.52711/0974-360X.2025.00033
Cite(Electronic):
Keerthana Chandrasekar, Taroob Runa T, Soorya U, Serolin S R, Manojkumar V. Dosage Optimization of Linezolid using Population Pharmacokinetics in South - Indian Pediatric Population. Research Journal of Pharmacy and Technology. 2025;18(1):217-0. doi: 10.52711/0974-360X.2025.00033 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-1-33
7. REFERENCES:
1. Wal Pranay, Wal Ankita, Srivastava Rishabh, Rastogi Prateek, Rai Awani K. Antibiotic Therapy in Pediatric Patients. Research J. Pharm. and Tech. 2010; 3(1): 118-120.
2. Swathi J., Vinitha E., Sudharsana KG, Vijisha R., Bincy Baby, Keerthana Chandrasekar. Prescription Auditing in Pediatric In-Patients at Secondary Care Hospital: A Cross Sectional Survey. Research J. Pharm. and Tech. 2020; 13(8): 3797-3800.
3. Keerthana Chandrasekar, Shruthi Jaya Saju, Brisha Hana Zechariah, Jenny Ann John, Sadagoban GK, Arun KP. Drug Utilization Evaluation of Aminoglycosides, Gentamicin and Amikacin: A Retrospective study in pediatric patients at secondary care public hospital. Research J. Pharm. and Tech. 2021; 14(3): 1247-1250.
4. Shihas Azeez, Linu Mohan Panakkal, Saleel Salman Meenpidiyil, Nafiya Sulaiman. Impact of Clinical Pharmacist Intervention in promoting Rational Antibiotic use in Pediatric patients. Research J. Pharm. and Tech. 2020; 13(11): 5077-5082.
5. Kishnani Khushboo, Bhandari Saloni, Rathore Kamal Singh. A Briefing of a Global Crisis: Antibiotic Resistance. Asian J. Res. Pharm. Sci. 2020; 10(4): 264-272. doi: 10.5958/2231-5659.2020.00047.8
6. Calhoun C, Wermuth HR, Hall GA. Antibiotics. StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK535443/
7. Lima LS, Brito Eda CA, Mattos K, Parisotto EB, Perdomo RT, Weber SS. A retrospective cohort study to screen linezolid-induced thrombocytopenia in adult patients hospitalized in the Midwestern region of Brazil. Hematology, Transfusion and Cell Therapy. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH) 2020: https://www.scielo.br/j/htct/a/9jztY85y9Z5cWgnjTWBjBQN/?lang=en
8. Suresh K. Sahu, Alpana Ram.Evaluation of Linezolid Loaded Ethosomes for Treatment of Deep Skin Infections in Diabetic Model. Research J. Pharm. and Tech. 2018; 11(7): 3023-3030.
9. Saiman L, Goldfarb J, Kaplan SA, Wible K, Edge-Padbury B, Naberhuis-Stehouwer S, et al. Safety and tolerability of linezolid in children. The Pediatric Infectious Disease Journal; 22(9 Suppl): S193-200. 2021 Oct https://pubmed.ncbi.nlm.nih.gov/14520146/
10. “Indian Pediatrics - Editorial.” Indianpediatrics.net, indianpediatrics.net/nov2004/nov1129-1132.htm https://indianpediatrics.net/nov2004/nov-1129-1132.htm
11. Bhuvaneshwari S, Umashankar M S, Damodharan N. Mini Tablets: Pediatric Drug Delivery System. Research J. Pharm. and Tech. 2020; 13(6): 2985-2991.
12. Population pharmacokinetics of linezolid: A systematic review https://d197for5662m48.cloudfront.net/documents/publicationstatus/76183/prepri nt_pdf/0814a360a5035630acd8b2dd0fb34623.pdf
13. Rao, Gauri G., et al. Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics. Therapeutic Drug Monitoring. 2020; 42(1): 83–92, 10.1097/ftd.0000000000000710.
14. FojCapell, Laura, et al. Determination of linezolid in human plasma by high- performance liquid chromatography for therapeutic drug monitoring. 2011; 4(4): 207–213, 10.1016/j.labcli.2011.06.006.
15. Kalyani Farkade, Vikrant Salode, Tejashri Kadu. Development and Validation of RP-HPLC Method for the Estimation of Linezolid from Bulk and Formulations. Asian Journal of Pharmaceutical Analysis. 2023; 13(4): 273-7. doi: 10.52711/2231-5675.2023.00045
16. Jawed Akhtar, Madhuri Baghel, Dharti Patel. Development of Analytical Method for Simultaneous Estimation of Cefixime and Linezolid in Tablet Dosage Form. Research J. Pharm. and Tech. 2013; 6(5): 592-594.
17. Yogita Dighe, R. B. Laware, S. B. Dighe. Analytical Method Development and Validation of Linezolidine – A Review. Research J. Science and Tech. 2020; 12(1): 13-22. doi: 10.5958/2349-2988.2020.00002.9
18. Platelet count. (2019, August 13). Ucsfhealth.org. https://www.ucsfhealth.org/medical-tests/platelet-count
19. Matsumoto, Kazuaki and Shigemi, Akari and Takeshita, Ayumi and Watanabe, Erika and Yokoyama, Yuta and Ikawa, Kazuro and Morikawa, Norifumi and Takeda, Yasuo. Linezolid dosage in pediatric patients based on pharmacokinetics and pharmacodynamics. Journal of Infection and Chemotherapy. 2014. 21. 10.1016/j.jiac.2014.08.017.
20. Soldin, OffiePorat, and Steven J. Soldin. Review: Therapeutic Drug Monitoring in Pediatrics. Therapeutic Drug Monitoring. 2002; 24(1): 1–8. 10.1097/00007691-200202000- 00001.